©The Author(s) 2026.
World J Clin Urol. Feb 12, 2026; 15(1): 114707
Published online Feb 12, 2026. doi: 10.5410/wjcu.v15.i1.114707
Published online Feb 12, 2026. doi: 10.5410/wjcu.v15.i1.114707
Table 5 Risk of urinary tract infections and their sequelae across different stages of chronic kidney disease in patients with urological causes
| CKD stage | Risk of UTI | Contributing factors | Common sequelae | Clinical implications |
| Stage 1-2 | Mild to moderate | (1) Structural abnormalities; and (2) Incomplete bladder emptying | (1) Occasional pyuria; and (2) Mild renal inflammation | Early detection and urological management can prevent progression |
| Stage 3 | Moderate | (1) Reduced renal clearance; and (2) Recurrent infections | (1) Accelerated GFR decline; and (2) Onset of antibiotic resistance | Close monitoring and tailored antimicrobial therapy are essential to slow progression |
| Stage 4 | High | (1) Impaired immune response; and (2) Chronic colonization | (1) Frequent hospitalizations; and (2) Risk of systemic infection | Repeated or resistant infections can hasten CKD progression; aggressive infection control is needed |
| Stage 5 (ESKD) | Very high | (1) Dialysis-related risks; and (2) Severe urinary tract dysfunction | (1) Sepsis; and (2) Multidrug-resistant organisms | Multidisciplinary care essential; infection prevention is critical |
- Citation: Elahi T, Ahmed S, Mubarak M. Urological footprint of chronic kidney disease: A nephrologist perspective on early detection and collaborative management. World J Clin Urol 2026; 15(1): 114707
- URL: https://www.wjgnet.com/2219-2816/full/v15/i1/114707.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v15.i1.114707